Skip to main content

Table 2 Clinical characteristics of the 30 patients in the control group

From: Neural stem cell-like cells derived from autologous bone mesenchymal stem cells for the treatment of patients with cerebral palsy

No. Gender GMFCS stage Age (years) LDQ GMFM
1 Female V 1 72 36
2 Female III 2.5 35 183
3 Male III 3.5 28 198
4 Male III 4 92 211
5 Male V 2 100 35
6 Male V 2 38 23
7 Male V 4.5 15 33
8 Male IV 3.5 27 110
9 Female V 2 75 51
10 Female IV 2.5 82 99
11 Male IV 1 60 80
12 Female III 15 95 201
13 Female III 1 62 135
14 Male IV 5 86 110
15 Female IV 2.5 95 98
16 Male IV 21 98 135
17 Male IV 35 82 90
18 Male IV 9 80 112
19 Female V 4 12 30
20 Female V 1 23 43
21 Male V 1.7 25 45
22 Female V 1 30 50
23 Female III 1.5 80 146
24 Female V 3 39 25
25 Male IV 2.5 96 99
26 Male V 2.6 100 28
27 Female III 2 86 100
28 Female V 1 65 45
29 Male III 1.5 85 125
30 Male V 1 64 43
  1. The clinical characteristics of the 30 patients in the control group are shown. GMFCS: Gross Motor Function Classification System levels; LDQ: language developmental quotient; GMFM: Gross Motor Function Measurement scores.